IMPURITIES AVAILABLE FOR 'Sorafenib Tosilate'

Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Sorafenib Tosilate. Sorafenib Tosylate is an oral multikinase inhibitor used primarily in the treatment of advanced renal cell carcinoma, hepatocellular carcinoma, and differentiated thyroid carcinoma. It works by inhibiting multiple intracellular and cell surface kinases involved in tumor cell proliferation and angiogenesis, including RAF kinases, VEGFR, and PDGFR. The tosylate salt form enhances its solubility and stability for oral administration. Sorafenib blocks tumor growth and blood vessel formation, thereby slowing cancer progression. It is taken orally, usually twice daily, with or without food. Common side effects include hand-foot skin reaction, diarrhea, hypertension, fatigue, and rash. Liver function monitoring is essential during therapy due to potential hepatotoxicity. Sorafenib Tosylate represents a significant advancement in targeted cancer therapy, offering improved survival and disease control in patients with advanced or treatment-resistant solid tumors. Buy high quality Sorafenib Tosilate from Omsynth Lifesciences.